Similar to the previous group, anti‐NT5C1A antibody seropositive non‐IBM IIM patients had a lower serum CK (P = 0.02) and a higher frequency of antinuclear antibody (45% vs. 18%; P < 0.01). This evidence concerns the gene NT5C1A and inclusion body myositis.